B

Benitec Biopharma
D

BNTC

10.473
USD
0.11
(1.09%)
Market Closed
Volume
565
EPS
-13
Div Yield
-
P/E
-4
Market Cap
243,145,619
News

Title: Benitec Biopharma

Sector: Healthcare
Industry: Biotechnology
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.